Symbols

EDIT

Editas Medicine·NASDAQ

--(--)

EDIT fundamentals

EDIT Q3 2025 Earnings

Editas Medicine (EDIT) released its earnings on Nov 10, 2025: revenue was 7.54M (YoY +12265.57%), beat estimates; EPS was -0.28 (YoY +62.67%), beat estimates.

Revenue / YoY

7.54M

+12265.57%

EPS / YoY

-0.28

+62.67%

Report date

Nov 10, 2025

Earnings

EPS

Revenue

Revenue & Expenses

EDIT has released its 2025 Q4 earnings report, with revenue of 24.74M, reflecting a YoY change of -19.16%, and net profit of -5.62M, showing a YoY change of 87.62%. The Sankey diagram below clearly presents EDIT's revenue sources and cost distribution.

Key Indicators

Editas Medicine (EDIT) key financial stats and ratios, covering profitability, financial health, and leverage.

Income Statement

Editas Medicine (EDIT)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.

Trend

Breakdown

Balance Sheet

Editas Medicine (EDIT)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.

Trend

Breakdown

Cash Flow

Editas Medicine (EDIT)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.

Trend

Breakdown